|
GBE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.94709999998566E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65380000003179E-06 |
| Normal-vs-Stage2 |
3.266200E-01 |
| Normal-vs-Stage3 |
5.829800E-01 |
| Normal-vs-Stage4 |
5.779600E-01 |
| Stage1-vs-Stage2 |
3.212400E-01 |
| Stage1-vs-Stage3 |
9.154300E-02 |
| Stage1-vs-Stage4 |
3.879600E-02 |
| Stage2-vs-Stage3 |
7.020600E-01 |
| Stage2-vs-Stage4 |
2.874200E-01 |
| Stage3-vs-Stage4 |
4.319200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83349999960392E-07 |
| Normal-vs-AfricanAmerican |
3.616400E-01 |
| Normal-vs-Asian |
8.806000E-01 |
| Caucasian-vs-AfricanAmerican |
1.502360E-01 |
| Caucasian-vs-Asian |
4.009000E-01 |
| AfricanAmerican-vs-Asian |
6.587600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95460003737935E-09 |
| Normal-vs-Female |
9.515200E-01 |
| Male-vs-Female |
1.080100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.559400E-01 |
| Normal-vs-Extreme_Weight |
2.6523228058295E-12 |
| Normal-vs-Obese |
2.465600E-01 |
| Normal-vs-Extreme_Obese |
1.622380E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.236300E-02 |
| Normal_Weight-vs-Obese |
8.018800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.897600E-01 |
| Extreme_Weight-vs-Obese |
1.116420E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.242600E-01 |
| Obese-vs-Extreme_Obese |
5.229600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.231600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.480900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.89029999992019E-07 |
| Normal-vs-Age(81-100Yrs) |
2.537900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.180400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.161600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.727400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.063600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.294200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.781800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.43305375846603E-12 |
| Normal-VS-Type2 PRCC |
8.258600E-01 |
| Normal-VS-KIRP CIMP |
5.966100E-02 |
| Normal-VS-Unclassified PRCC |
1.431430E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.575700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.757500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.578570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.173550E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.144460E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.235900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.126400E-02 |
| Normal-vs-N1 |
8.016400E-01 |
| Normal-vs-N2 |
7.664800E-01 |
| N0-vs-N1 |
3.930200E-01 |
| N0-vs-N2 |
8.706800E-01 |
| N1-vs-N2 |
8.316800E-01 |
|
|
